University of Vermont Cancer Center — Burlington, Vermont

University of Vermont Cancer Center is a clinical research site located in Burlington, Vermont, United States 05401.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Vermont Cancer Center has participated in 6 clinical trials with 3 currently active.

Therapeutic areas: Breast Cancer, Carcinoma of the Breast, Leukemia, Myeloid, Acute.

Sponsors: Dana-Farber Cancer Institute, Delta-Fly Pharma, Inc., Endocyte.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Vermont Cancer Center?

University of Vermont Cancer Center has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Vermont Cancer Center conducted?

University of Vermont Cancer Center has 6 clinical trials on record, with 3 currently active. Their work covers Breast Cancer, Carcinoma of the Breast, Leukemia, Myeloid, Acute.

Is University of Vermont Cancer Center accredited by Crixeo Health?

Yes — University of Vermont Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Vermont Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.